Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia

Sponsor
University Hospital Schleswig-Holstein
Study ID
NCT07151339
Status
Recruiting
Apply to this trial

Conditions

  • Eclampsia
  • HELLP Syndrome
  • Kidney Disease
  • Preeclampsia

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Tertiary prevention program for women with preeclampsia, HELLP syndrome, kidney disease and pregnancy or associated conditions, including founding of a biobank. (Observational study since no interference with regular path of treatment suggested in national and international guidelines)

Key Dates

First listed
Sep 3, 2025
Start date
Nov 1, 2024
Status verified
Aug 2025
Primary completion
Nov 30, 2029
Completion
Nov 30, 2030

Study Design

Enrollment
100 participants (estimated)

Primary Outcome Measure

Pulse wave velocity [ Time Frame: 12 months ]

Central Contacts

Related Studies